2012
DOI: 10.1016/j.eururo.2012.01.018
|View full text |Cite
|
Sign up to set email alerts
|

A Randomized Prospective Trial to Assess the Impact of Transurethral Resection in Narrow Band Imaging Modality on Non–Muscle-Invasive Bladder Cancer Recurrence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
68
1
2

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 107 publications
(72 citation statements)
references
References 18 publications
1
68
1
2
Order By: Relevance
“…There have been few previous comparisons of recurrence in NMIBC following NBI-TUR and WLI-TUR (4). The significantly lower recurrence rate with NBI-TUR compared to WLI-TUR may be due to the significantly higher tumor detection rate with NBI-TUR found in the NMIBC patients in the present study and in previous studies (4)(5)(6)(7)(8)(9).…”
Section: Discussionmentioning
confidence: 32%
See 2 more Smart Citations
“…There have been few previous comparisons of recurrence in NMIBC following NBI-TUR and WLI-TUR (4). The significantly lower recurrence rate with NBI-TUR compared to WLI-TUR may be due to the significantly higher tumor detection rate with NBI-TUR found in the NMIBC patients in the present study and in previous studies (4)(5)(6)(7)(8)(9).…”
Section: Discussionmentioning
confidence: 32%
“…The tumor recurrence rate at 3 months after TUR in NMIBC may also reflect the skill of the surgeon (4,11,12). Without additional post-operative treatment, recurrence rates of 3.4 to 20.6% and 7.4 to 45.8% have been found in patients with single and multiple tumors, respectively (11).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[32] Herr et al [33] evaluated 103 patients with recurrent NMIBC, and although 87% of the recurrences were able to be seen with WLC, 100% of the lesions were visualized with NBI. Naselli et al [34] performed a prospective randomized control study powered to report a 10% difference in recurrence at 1 year and, indeed, found the recurrence risk using NBI versus WLC during TURBT to be 33% versus 51%, respectively. Montanari et al [35] later confirmed these results with a prospective trial that reported recurrence rates at 1 year of 35% with NBI compared with 50% with only WLC.…”
Section: Narrow Band Imaging (Nbi)mentioning
confidence: 99%
“…Ezeken túl el nem hanyagolható há-nyadot képeznek a műtét során észre nem vett apró daganatok is. Amellett, hogy újabb műtét szükséges ahhoz, hogy a beteg daganatmentessé váljon, nem kerülhető el az a tény sem, hogy a beavatkozások ismétlése jelentős terhet ró az amúgy is minimális tartalékokkal rendelkező egészségügyi rendszerünkre, nem beszélve a beteg szociális, pszichés és ál-talános egészségi állapotáról (8,9,10). Az utánkövetés során a képalkotó eljárások mellett alapvető fontosságú a vizeletcitológia (G3 tumor esetén) és a cisztoszkópia.…”
unclassified